PAVM
PAVmed Inc

8,815
Mkt Cap
$8.53M
Volume
154,994.00
52W High
$0.895
52W Low
$0.2715
PE Ratio
-0.50
PAVM Fundamentals
Price
$0.2875
Prev Close
$0.3002
Open
$0.292
50D MA
$0.3704
Beta
1.30
Avg. Volume
554,362.11
EPS (Annual)
$0.4961
P/B
0.78
Rev/Employee
$76,794.87
Loading...
Loading...
News
all
press releases
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection Lucid Diagnostics Announces Positive Data from the Largest Reported...
PR Newswire·16d ago
News Placeholder
More News
News Placeholder
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire NEW YORK, Nov. 20, 2025...
PR Newswire·1mo ago
News Placeholder
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and...
PR Newswire·1mo ago
News Placeholder
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 13, 2025...
PR Newswire·1mo ago
News Placeholder
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW...
PR Newswire·1mo ago
News Placeholder
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PR Newswire NEW YORK, Oct. 30, 2025...
PR Newswire·2mo ago
News Placeholder
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire...
PR Newswire·2mo ago
News Placeholder
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK, Oct. 15, 2025 NEW YORK, Oct. 15, 2025...
PR Newswire·2mo ago
News Placeholder
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why
PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks·3mo ago
<
...
1
>

Latest PAVM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.